| Name | Title | Contact Details |
|---|
At Neopenda, we believe that the most vulnerable patient populations in the world deserve access to high quality health care. We re a social enterprise startup passionate about improving newborn health through innovative technology solutions, and implementing them sustainably in emerging markets. Neopendas first product is a scalable wireless vital signs monitor for patients in overcrowded, understaffed health facilities. Our solution reduces response time to newborns in distress, and helps healthcare workers to save more lives. We are currently validating our technology in clinical studies with our partners in Uganda.
NeuroMetrix Inc. is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Formed in 2019, through the merger of Sivantos and Widex, WS Audiology combines more than 140 years experience in pioneering the use of technology to help people with hearing loss hear the sounds that make life wonderful. Today, one out of three hearing aids is made by us and we are active in over 125 markets, employing close to 12,000 people worldwide. Our broad portfolio of leading hearing-related products and services generates annual revenues of more than € 2 billion. WS Audiology is privately owned by the Tøpholm and Westermann families, as well as funds under the management of EQT. As a global leader, our ambition is to unlock human potential by making wonderful sound part of everyone`s life.
OrthoPediatrics Corp is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 1988 in Queensbury, N.Y., U.S., AngioDynamics is today a NASDAQ-listed public company. We are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. Our diverse product line includes market-leading radiofrequency ablation and NanoKnife® systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. AngioDynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the company’s consistent ability to successfully develop and bring to market new technologies and products. AngioDynamics believes it is well poised to continue that trend. Looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patient care by providing the highest-quality, best-performing products.